Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization. | Acta Pharm Sin B | 2022 | 35755286 | PubTator, text mining | PubMed |
| A dual-activity topoisomerase complex regulates mRNA translation and turnover. | Nucleic Acids Res | 2022 | 35748872 | PubTator, text mining | PubMed |
| Identification of pathways and key genes in male late-stage carotid atherosclerosis using bioinformatics analysis. | Exp Ther Med | 2022 | 35747144 | PubTator, text mining | PubMed |
| Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review. | Nutrients | 2022 | 35745251 | PubTator, text mining | PubMed |
| Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells. | Biomolecules | 2022 | 35740975 | PubTator, text mining | PubMed |
| Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. | Biomedicines | 2022 | 35740310 | PubTator, text mining | PubMed |
| Ochratoxin A and Kidney Oxidative Stress: The Role of Nutraceuticals in Veterinary Medicine-A Review. | Toxins (Basel) | 2022 | 35737059 | PubTator, text mining | PubMed |
| Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates. | World J Surg Oncol | 2022 | 35729567 | PubTator, text mining | PubMed |
| Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. | Eur Respir J | 2022 | 35728978 | PubTator, text mining | PubMed |
| Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses. | Cell Chem Biol | 2022 | 35728599 | PubTator, text mining | PubMed |
| Macrophages derived from pluripotent stem cells: prospective applications and research gaps. | Cell Biosci | 2022 | 35725499 | PubTator, text mining | PubMed |
| ICOS Gene Polymorphisms (IVS1 + 173 T/C and c. 1624 C/T) in Primary Sjögren's Syndrome Patients: Analysis of ICOS Expression. | Curr Issues Mol Biol | 2022 | 35723338 | PubTator, text mining | PubMed |
| The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease. | Front Cell Dev Biol | 2022 | 35721513 | PubTator, text mining | PubMed |
| The Genetic Landscape of Cutaneous Lupus Erythematosus. | Front Med (Lausanne) | 2022 | 35721085 | PubTator, text mining | PubMed |
| LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer. | Oncol Lett | 2022 | 35720504 | PubTator, text mining | PubMed |
| Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development. | Front Immunol | 2022 | 35720390 | PubTator, text mining | PubMed |
| RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35720121 | PubTator, text mining | PubMed |
| Biological Characterization and Clinical Value of OAS Gene Family in Pancreatic Cancer. | Front Oncol | 2022 | 35719943 | PubTator, text mining | PubMed |
| Construction of a competing endogenous RNA network to analyse glucose-6-phosphate dehydrogenase dysregulation in hepatocellular carcinoma. | Biosci Rep | 2022 | 35712981 | PubTator, text mining | PubMed |
| Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus. | Front Med (Lausanne) | 2022 | 35712102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=50